Double maintains 3 strategies that include CLVT - Clarivate Plc
Current Value
$4.311 Year Return
Current Value
$4.311 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -31.64% | $361.41M | 1.43% |
TAIL | -28.11% | $140.49M | 0.59% |
VIXY | -27.51% | $109.64M | 0.85% |
IVOL | -27.47% | $353.94M | 1.02% |
KCCA | -13.27% | $97.18M | 0.87% |
USDU | -12.82% | $173.44M | 0.5% |
UUP | -11.72% | $292.27M | 0.77% |
FTSD | -9.33% | $212.46M | 0.25% |
STPZ | -5.88% | $446.46M | 0.2% |
BIL | -5.51% | $45.95B | 0.1356% |
TBLL | -4.06% | $2.46B | 0.08% |
CORN | -3.92% | $49.57M | 0.2% |
VTIP | -3.42% | $14.78B | 0.03% |
XONE | -3.36% | $603.24M | 0.03% |
SHYM | -2.37% | $322.93M | 0.35% |
SPTS | -1.71% | $5.76B | 0.03% |
FXY | -1.39% | $838.61M | 0.4% |
IBDQ | -0.93% | $3.08B | 0.1% |
BILS | -0.93% | $3.96B | 0.1356% |
TFLO | -0.53% | $7.06B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
MOAT | 52.32% | $13.02B | 0.47% |
FXH | 51.91% | $891.82M | 0.62% |
PBD | 51.49% | $70.89M | 0.75% |
MOO | 49.08% | $599.45M | 0.53% |
PBW | 48.47% | $269.08M | 0.65% |
ACES | 48.16% | $105.58M | 0.55% |
RSPH | 48.15% | $754.08M | 0.4% |
INCM | 47.56% | $605.42M | 0.38% |
QCLN | 47.54% | $417.91M | 0.59% |
FBT | 47.52% | $994.71M | 0.56% |
AOM | 47.30% | $1.50B | 0.15% |
VEGI | 47.21% | $96.79M | 0.39% |
ERTH | 47.18% | $150.05M | 0.67% |
LCTD | 46.08% | $228.15M | 0.2% |
HYDB | 46.04% | $1.61B | 0.35% |
UPAR | 46.04% | $57.67M | 0.65% |
SMOT | 46.02% | $363.89M | 0.49% |
BBH | 45.97% | $327.42M | 0.35% |
QVAL | 45.73% | $376.57M | 0.29% |
IJAN | 45.71% | $195.23M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
WEAT | -0.07% | $115.83M | 0.28% |
STIP | 0.17% | $11.88B | 0.03% |
GBIL | -0.38% | $6.17B | 0.12% |
TPMN | -0.45% | $31.54M | 0.65% |
TFLO | -0.53% | $7.06B | 0.15% |
UTWO | 0.84% | $387.71M | 0.15% |
BILS | -0.93% | $3.96B | 0.1356% |
IBDQ | -0.93% | $3.08B | 0.1% |
TDTT | 1.30% | $2.47B | 0.18% |
SCHO | 1.39% | $10.87B | 0.03% |
FXY | -1.39% | $838.61M | 0.4% |
SPTS | -1.71% | $5.76B | 0.03% |
VGSH | 1.77% | $22.38B | 0.03% |
CTA | 1.78% | $1.05B | 0.76% |
BILZ | 2.14% | $876.85M | 0.14% |
KRBN | 2.17% | $160.09M | 0.85% |
SHYM | -2.37% | $322.93M | 0.35% |
ULST | 2.38% | $637.77M | 0.2% |
UNG | 2.46% | $371.83M | 1.06% |
TBIL | 2.50% | $5.76B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BPT | -0.03% | $13.70M | -73.66% | 0.00% |
SYPR | 0.12% | $37.69M | +21.48% | 0.00% |
HUM | -0.12% | $27.45B | -35.96% | 1.55% |
UTZ | 0.21% | $1.11B | -29.27% | 1.86% |
ORLY | 0.22% | $78.08B | +36.20% | 0.00% |
MUSA | 0.46% | $8.91B | +2.63% | 0.53% |
GO | -0.61% | $1.37B | -35.98% | 0.00% |
TEO | 0.61% | $1.39B | +20.92% | 0.00% |
NEUE | -0.63% | $62.05M | +13.56% | 0.00% |
TGI | 0.64% | $1.99B | +73.56% | 0.00% |
HEES | -0.69% | $3.52B | +99.54% | 1.15% |
MSIF | -0.70% | $715.25M | +28.42% | 7.05% |
AJG | 0.71% | $86.63B | +32.39% | 0.72% |
ZCMD | 0.74% | $32.45M | -11.38% | 0.00% |
WRB | 0.75% | $27.58B | +41.40% | 0.50% |
TMCI | 0.83% | $424.61M | +19.89% | 0.00% |
CME | 0.88% | $98.74B | +28.80% | 3.84% |
QURE | -0.88% | $725.42M | +161.34% | 0.00% |
BTCT | 1.12% | $25.35M | +93.08% | 0.00% |
AMED | 1.17% | $3.08B | -1.30% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GEO | -18.86% | $3.80B | +103.25% | 0.00% |
FMTO | -15.52% | $45.74M | -99.96% | 0.00% |
MCK | -14.21% | $88.42B | +27.17% | 0.39% |
CXW | -13.95% | $2.39B | +45.07% | 0.00% |
LUMN | -13.68% | $4.29B | +219.08% | 0.00% |
MRCY | -12.17% | $2.74B | +46.88% | 0.00% |
COR | -11.63% | $55.43B | +28.90% | 0.56% |
KR | -11.43% | $44.68B | +24.17% | 1.89% |
SAVA | -8.60% | $99.03M | -90.49% | 0.00% |
IRWD | -7.80% | $96.19M | -91.05% | 0.00% |
STG | -7.01% | $27.05M | -37.35% | 0.00% |
SAFT | -5.98% | $1.23B | +2.09% | 4.33% |
USM | -5.40% | $5.19B | +38.83% | 0.00% |
LITB | -4.55% | $21.28M | -72.45% | 0.00% |
UFCS | -4.50% | $725.86M | +20.95% | 2.26% |
AMSF | -4.40% | $905.27M | +7.85% | 3.16% |
VSTA | -4.01% | $326.82M | +11.64% | 0.00% |
HMN | -3.36% | $1.74B | +22.22% | 3.21% |
RYAM | -3.31% | $261.09M | -13.69% | 0.00% |
TDS | -3.29% | $3.93B | +68.38% | 0.46% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IFF | 51.18% | $19.47B | -22.18% | 2.09% |
PACS | 51.04% | $1.65B | -62.33% | 0.00% |
SMG | 50.45% | $3.53B | -11.79% | 4.30% |
SWK | 50.43% | $10.94B | -21.26% | 4.60% |
MFA | 50.01% | $1.01B | -10.64% | 14.30% |
TECH | 49.46% | $7.56B | -41.77% | 0.49% |
AVNW | 48.91% | $263.49M | -34.51% | 0.00% |
JLL | 48.42% | $11.18B | +13.49% | 0.00% |
W | 47.47% | $4.97B | -43.57% | 0.00% |
LEG | 46.93% | $1.29B | -21.98% | 2.10% |
BRKR | 46.32% | $5.56B | -51.61% | 0.54% |
SPB | 45.82% | $1.61B | -30.85% | 2.73% |
RUN | 45.29% | $2.94B | +4.90% | 0.00% |
RVTY | 45.14% | $10.66B | -16.65% | 0.31% |
CSIQ | 45.12% | $715.82M | -33.44% | 0.00% |
GEHC | 44.92% | $33.38B | -10.33% | 0.18% |
FBIN | 44.35% | $6.57B | -25.26% | 1.76% |
TXG | 44.33% | $1.15B | -64.05% | 0.00% |
DHR | 44.27% | $136.66B | -27.90% | 0.60% |
GIL | 44.08% | $7.46B | +38.71% | 1.71% |
Yahoo
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the Trademark filing trends 2025 report, analyzing ten key trademark registers worldwide: the United States (U.S.), Canada, the United Kingdom (U.K.), the European Union (EU), France, Germany, India, Mainland China, Japan, and Australia. The report reveals the top 20 largest local and foreign-based trademark portfolios in each region and the law firms managing the largest trademark portfolios.
SeekingAlpha
Exelixis delivers a strong Q1 performance with raised 2025 guidance, robust Cabometyx sales, and share buybacks. Read the latest EXEL stock analysis here.
Yahoo
Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence solution. With over 30% of drug development failures attributed to safety issues1, preclinical and translational research teams face increasing pressure to identify potential liabilities earlier in the target selection process. Pathway Maps provide powerful visual tools that offer deeper insights into the
SeekingAlpha
Clarivate (CLVT) is a buy as 1Q25 marks a turning point with organic growth, stronger renewals, and a robust revenue mix. Read an analysis here.
Yahoo
Shareholders will be ecstatic, with their stake up 23% over the past week following Clarivate Plc 's ( NYSE:CLVT...
Finnhub
Fitch Ratings has affirmed Clarivate Plc's Long-Term Issuer Default Rating at 'BB-' and affirmed the IDRs of its subsidiaries and borrowers Camelot U.S. Acquisition LLC, Camelot Finance S.A., and...